Oxcarbazepine Tablet, Film Coated, Extended Release
Product Images NDC 59651-786

4 FDA label images from Aurobindo Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 59651-786). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Str (Oxcarbazepine Str)

Str (Oxcarbazepine Str)
Chemical structure of oxcarbazepine, showing its fused ring system and functional groups as a structural formula diagram.*
FDA Label Image

Package Label-principal Display Panel (150 mg)

Package Label-principal Display Panel (150 mg)
Label for Oxcarbazepine Extended-Release Tablets 150 mg, film-coated tablets for oral use. The label states 'Rx only' and indicates a package size of 100 tablets. It includes storage instructions, manufacturer details for Aurobindo Pharma USA, Inc., and a barcode. The label emphasizes swallowing whole and dispensing the Medication Guide to patients.*
FDA Label Image

Package Label-principal Display Panel (300 mg)

Package Label-principal Display Panel (300 mg)
Oxcarbazepine Extended-Release Tablets 300 mg film-coated tablets in a package of 100 tablets. The label includes dosage instructions to swallow whole and not to cut, crush or chew. It is distributed by Aurobindo Pharma USA, Inc. and indicates storage temperature guidelines and a note for pharmacists to dispense the medication guide separately.*
FDA Label Image

Package Label-principal Display Panel (600 mg)

Package Label-principal Display Panel (600 mg)
Label for Oxcarbazepine Extended-Release Tablets 600 mg, film-coated oral tablets, with a quantity of 100 tablets per container. The label includes the NDC 59651-787-01 and indicates it is a prescription drug. Distributed by Aurobindo Pharma USA, Inc., made in India, with storage instructions and a notice to swallow whole without cutting, crushing, or chewing. The label also references a medication guide and includes a barcode and coding area for printing serialization and expiration details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.